Medpace Holdings, Inc. · NASDAQ:MEDP

Medpace — Fact Sheet (March 2023)

2 slides from Medpace's fact sheet, March 2023

  1. Slide 1: The Medpace Difference for Cellular & Gene Therapy Clinical Development

    THE MEDPACE DIFFERENCE FOR CELLULAR & GENE THERAPY CLINICAL DEVELOPMENT Medpace is a pioneer in the clinical development of cellular and gene therapies, contributing to over 130 clinical trials UTED TO OV TRIB and two approved therapies. Our team offers Sponsors TWO N ER APPROVED comprehensive soluti

  2. Slide 2: A Proven Approach to Complex Studies

    A PROVEN APPROACH TO COMPLEX STUDIES Our experienced global teams are specialized experts in clinical, regulatory, and operations that evaluate each study to determine the best operational strategy. CELLULAR AND GENE EXPERTISE GLOBAL, FULL-SERVICE OPERATIONAL SUPPORT & SERVICES ADVANCED PATIENT PATI

Medpace Holdings — Fact Sheet (March 2023) on 6ix